Last reviewed · How we verify

NCT06286969

Clinical Study on Intensive Multi-acupuncture in the Treatment of Lumbar Muscle Strain.

Status unknown NA Last updated 29 February 2024
What this trial tests

NA trial testing acupuncture in Lumbar Muscle Strain in 108 participants. Status unknown.

Timeline
1 March 2024
Primary endpoint
31 December 2024
1 March 2025

Quick facts

Lead sponsorXu Xinnan
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment108
Start date1 March 2024
Primary completion31 December 2024
Estimated completion1 March 2025

Drugs / interventions tested

Conditions studied

Sponsor

Xu Xinnan

Who can join

Adults 18 to 70, any sex, with Lumbar Muscle Strain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acupuncture is widely used as a routine treatment for lumbar muscle strain. The aim of this randomized controlled trial is to evaluate the effectiveness of the intensive multi-acupuncture method. This trial will include 108 patients with lumbar muscle strain injury from two outpatient clinics. All participants will be randomized in a 1:1 ratio to the intensive multi-acupuncture method group and the normal needling group. Outcomes will be assessed before the intervention, after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment. The primary outcome indicator will be the clinical efficacy evaluation criteria, and the secondary outcome indicators will be the pain visual analog scale (VAS) score, the Japanese Orthopaedic Association Assessment Treatment Score (JOA) score, the lumbar joint mobility measurement scale, and the Modified Ashworth Grading Scale. This study will provide evidence as to whether the intensive multi-acupuncture method is safe and effective.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of acupuncture

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06286969.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing